Periodic Reporting for period 1 - ImmunoNet (Inhibiting resistance to immunotherapy in Oncology by targeting Netrin-1)

Immune Checkpoint Inhibitors (ICPIs) have recently revolutionized the treatment and management of cancer. Yet, progress recorded and impact on long-term survival affect only a limited fraction of patients, as most cancer patients do not or incompletely respond to ICPIs due to...